Open Access

TGF-β3 reduces apoptosis in ischemia-induced adipose-derived stem cells by enhancing DNA repair

  • Authors:
    • Fan Wu
    • Haiwen Ye
    • Junfeng Lin
    • Yaodong Xu
    • Zhuasong Zhang
    • Hao Xiong
    • Maojin Laing
    • Yiqing Zhen
    • Suijun Chen
  • View Affiliations

  • Published online on: March 21, 2018     https://doi.org/10.3892/etm.2018.5980
  • Pages: 4400-4408
  • Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Adipose‑derived stem cells (ADSCs) possess good proliferative and differentiative abilities, making then a promising candidate for the treatment of cartilage defects. However, local ischemia often causes apoptosis in ADSCs. Transforming growth factor‑β3 (TGF‑β3) is often used as a chondrogenic differentiation cytokine whose function in apoptosis is unclear. The aim of the present study was to investigate the role of TGF‑β3 in ischemia‑induced ADSC apoptosis. In the present study, the phenotypes and multipotent differentiation properties of human ADSCs at passage 3 were analyzed using flow cytometry and cytochemical staining. ADSCs were cultured in a serum‑ and glucose‑free medium under hypoxic conditions with or without exogenous TGF‑β3 treatment. The apoptosis rate was measured using a TUNEL array and Annexin V/propidium iodide staining. The expression of apoptosis‑associated proteins was measured using western blotting. The results revealed ADSCs cultured in normal condition have multi‑lineage differentiation potential and high levels of cluster of differentiation (CD)29, CD44 and CD105 expression. Furthermore, ADSCs weakly express CD14, CD34 and CD45, with strong clone formation and migration abilities. Serum deprivation under hypoxic conditions resulted in mitochondria‑mediated apoptosis in ADSCs, which was attenuated by exogenous TGF‑β3 treatment via upregulation of poly ADP‑ribose polymerase (PARP). The results of the present study indicate that TGF‑β3 is able to protect ADSCs from ischemia‑induced apoptosis via PARP‑associated DNA damage repair.
View Figures
View References

Related Articles

Journal Cover

May-2018
Volume 15 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu F, Ye H, Lin J, Xu Y, Zhang Z, Xiong H, Laing M, Zhen Y and Chen S: TGF-β3 reduces apoptosis in ischemia-induced adipose-derived stem cells by enhancing DNA repair. Exp Ther Med 15: 4400-4408, 2018.
APA
Wu, F., Ye, H., Lin, J., Xu, Y., Zhang, Z., Xiong, H. ... Chen, S. (2018). TGF-β3 reduces apoptosis in ischemia-induced adipose-derived stem cells by enhancing DNA repair. Experimental and Therapeutic Medicine, 15, 4400-4408. https://doi.org/10.3892/etm.2018.5980
MLA
Wu, F., Ye, H., Lin, J., Xu, Y., Zhang, Z., Xiong, H., Laing, M., Zhen, Y., Chen, S."TGF-β3 reduces apoptosis in ischemia-induced adipose-derived stem cells by enhancing DNA repair". Experimental and Therapeutic Medicine 15.5 (2018): 4400-4408.
Chicago
Wu, F., Ye, H., Lin, J., Xu, Y., Zhang, Z., Xiong, H., Laing, M., Zhen, Y., Chen, S."TGF-β3 reduces apoptosis in ischemia-induced adipose-derived stem cells by enhancing DNA repair". Experimental and Therapeutic Medicine 15, no. 5 (2018): 4400-4408. https://doi.org/10.3892/etm.2018.5980